Meloxicam G.L.

Meloxicam, the active ingredient in Meloxicam G.L., is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular use. It is indicated for the management of osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain, and post‑operative pain in adult patients.

GNH USA supplies Meloxicam G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with the product sourced from the European Union market. The company follows stringent quality standards and provides regulatory documentation for importers, ensuring product integrity throughout the supply chain.

Meloxicam is an NSAID that reduces inflammation and pain in musculoskeletal disorders.

Osteoarthritis: reduces joint pain and improves mobility Rheumatoid arthritis: alleviates inflammatory joint swelling and pain Acute musculoskeletal pain: provides rapid analgesic effect for injuries and strains Post‑operative pain: controls surgical site discomfort and facilitates recovery

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort (nausea, dyspepsia) - Headache - Dizziness - Injection site pain

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Renal impairment or acute kidney injury

When using Meloxicam, clinicians should observe several safety precautions to minimize risk.

Assess renal function: monitor serum creatinine and adjust use in renal impairment. Evaluate hepatic status: avoid in severe liver disease and monitor liver enzymes. Use caution in cardiovascular disease: increased risk of thrombotic events. Avoid use in third‑trimester pregnancy: category C and potential fetal harm. Review concomitant NSAIDs or anticoagulants: heightened bleeding risk. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meloxicam can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal function.

Moderate Interactions (Monitor Closely): - Diuretics: possible electrolyte disturbances and renal effects. - SSRIs or SNRIs: enhanced bleeding tendency.